Pilot Study of Reduced Venetoclax Exposure

NCT07163793 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia in Remission

Interventions

DRUG: Azacitidine
DRUG: Decitabine
DRUG: Venetoclax

Sponsor

Northwell Health